1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.52%
Revenue growth 1.25-1.5x 6247.T's 16.10%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
3.07%
Gross profit growth under 50% of 6247.T's 9.00%. Michael Burry would be concerned about a severe competitive disadvantage.
-23.79%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.85%
Negative operating income growth while 6247.T is at 35.80%. Joel Greenblatt would press for urgent turnaround measures.
-39.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-40.07%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-40.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.94%
10Y revenue/share CAGR under 50% of 6247.T's 60.03%. Michael Burry would suspect a lasting competitive disadvantage.
70.25%
5Y revenue/share CAGR above 1.5x 6247.T's 20.22%. David Dodd would look for consistent product or market expansions fueling outperformance.
51.85%
Positive 3Y CAGR while 6247.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.55%
Negative 10Y net income/share CAGR while 6247.T is at 32.81%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-95.82%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
109.89%
3Y net income/share CAGR above 1.5x 6247.T's 43.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
284.19%
10Y equity/share CAGR above 1.5x 6247.T's 50.73%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
35.04%
5Y equity/share CAGR above 1.5x 6247.T's 15.53%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
26.04%
3Y equity/share CAGR above 1.5x 6247.T's 8.31%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.25%
AR growth is negative/stable vs. 6247.T's 5.47%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.64%
Inventory growth well above 6247.T's 8.10%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.58%
Asset growth 1.25-1.5x 6247.T's 1.14%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
-0.22%
We have a declining book value while 6247.T shows 0.64%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.58%
We have some new debt while 6247.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
1.28%
R&D dropping or stable vs. 6247.T's 11.11%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-17.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.